ADAM17 and nonpapillary renal cell carcinoma: In our cohort of 38 ccRCC patients, ADAM17 expression was significantly elevated in tumors and positively correlated with higher Fuhrman grade and advanced T stage (Figure S3E,F, Supporting Information).